Essex Investment Management Co. LLC Has $2.77 Million Stake in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Essex Investment Management Co. LLC cut its stake in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 14.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 1,212,964 shares of the company’s stock after selling 197,165 shares during the quarter. Essex Investment Management Co. LLC’s holdings in Stereotaxis were worth $2,766,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in STXS. SG Americas Securities LLC raised its position in shares of Stereotaxis by 39.2% during the fourth quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock worth $60,000 after acquiring an additional 7,417 shares during the last quarter. Jane Street Group LLC increased its position in Stereotaxis by 26.9% during the 3rd quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after purchasing an additional 6,313 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Stereotaxis in the 4th quarter worth approximately $101,000. Wealth Effects LLC lifted its position in shares of Stereotaxis by 11.7% in the 4th quarter. Wealth Effects LLC now owns 86,060 shares of the company’s stock worth $196,000 after purchasing an additional 9,000 shares during the period. Finally, Barclays PLC boosted its stake in shares of Stereotaxis by 449.9% in the 3rd quarter. Barclays PLC now owns 101,953 shares of the company’s stock valued at $208,000 after purchasing an additional 83,412 shares during the last quarter. Institutional investors own 45.35% of the company’s stock.

Stereotaxis Price Performance

Shares of NYSEAMERICAN STXS opened at $1.87 on Monday. The company has a market capitalization of $158.45 million, a P/E ratio of -6.68 and a beta of 1.54. The business’s fifty day moving average price is $2.27. Stereotaxis, Inc. has a twelve month low of $1.66 and a twelve month high of $3.29.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.